top of page
JPEG format LBV.jpg
header linkedin 2.png

 Lean Ways To Develop Medicines

Landmark BioVentures AG (LBV), founded in 2021 and headquartered in Basel, Switzerland, is an integrated and agile biotech hub-and-spoke company.

LBV takes a unique model focused on lean operations, smart capital allocation, and diversified yet complementary nexus of 7 companies developing 10 first-in-class therapeutics. 

Landmark BioVentures Unique Model

LBV Nexus.jpg

Nexus of New Biotech Ventures 

Roca.png
logo Elikya.png
Kekkan.png
carla.png
Logo SPIMA.png
Duhn Therapeutics_Logo.png
Logo Massalia.png

Founders & Partners

Zaki Photo.png

Zaki Sellam


CEO

  • Grey LinkedIn Icon

• 20+ years of experience in Biotech

• Expert in Immuno-Oncology Drug Development

• Involved in multiple start-ups & more than 40 Deals

• Strong CRO and Academic network

• Board Member of Swiss Healthcare Licensing Group & Basel BioValley Association

Gary Photo-2.jpg

Gary Brandam


COO

 

  • Grey LinkedIn Icon
  • 12+ years of experience in Biotech and Pharma

  • Led development of 4 program in oncology start-ups

  • Strong expertise in l commercialization of Oncology and Rare Disease assets

  • Expert in launch excellence in oncology and rare disease

Jacques Photo_2.png

Jacques Bauer, PhD


 CDO
 

  • Grey LinkedIn Icon
  • 35+ years of experience in Biopharma

  • Scientist, medicinal chemist and biologist

  • Former R&D Director at OM Pharma

  • Expert in drug discovery, drug development in oncology, immunology and metabolic diseases

  • Strong expertise in intellectual property

Mehdi Photo.png

Mehdi Chelbi


 CBO


 

  • Grey LinkedIn Icon
  • 20+ years of experience in in Biotech, Pharma and CROs

  • Entrepreneur and C-Level positions

  • Expert in corporate development and fundraising

  • Strong expertise in Preclinical and clinical development execution

  • Involved in the design, planning and setup of 300+ trials

Samson Fung, MD

CMO

 

  • Grey LinkedIn Icon
  • 30+ years of experience in Biotech and Pharma

  • Physician by training in oncology and hematology

  • Former CEO of Volvox Therapeutics

  • Expert in clinical development, medical affairs market access 

  • Spent 15+ years in pharma including Roche, Novartis, Novo Nordisk and Astra Zeneca

JPEG format LBV.jpg

Bernouillistrasse 20
Basel CH-4056
Switzerland

bottom of page